Neuronetics Market Risk Adjusted Performance
| STIM Stock | | | USD 1.45 0.10 7.41% |
This dataset for Neuronetics reflects inputs used in the Market Risk Adjusted Performance calculation. All values reflect available price and volume data across reporting intervals. Data availability for the calculation period determines indicator completeness. Neuronetics has a market cap of 103.76 M, operating margin of -11.11%, ROE of -134.86%. For allocation context, review
World Market Map. Allocation details are provided as informational context. Allocation context is based on the most recent position data. The allocation includes a position in Neuronetics. It is distributed across the allocation. The weighting is determined by the allocation framework in use. This summary reflects available observations without forecasting intent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in gross domestic product.
New to investing in Neuronetics Stock? Start with our
How to Invest in Neuronetics Stock guide for a step-by-step overview.
Neuronetics has current Market Risk Adjusted Performance of
-0.1.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | -0.1 | |
| ER[a] | = | Expected return on investing in Neuronetics |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Market Risk Adjusted Performance Peers Comparison
Market Risk Adjusted Performance Relative To Other Indicators
Neuronetics lands at
#5 in market risk adjusted performance compared to key competitors. It is currently under evaluation in maximum drawdown compared to key competitors .
Other Technical Indicators